Can a natural supplement shield the aging brain from Surgery's mental fog?

NCT ID NCT07681063

First seen Jul 02, 2026 · Last updated Jul 02, 2026

Summary

This study tests whether a combination of palmitoylethanolamide and luteolin (PEALut), taken as an oral supplement for three months after heart surgery, can help prevent or reduce cognitive decline in adults aged 65 and older. The supplement aims to calm brain inflammation and oxidative stress, which are thought to contribute to postoperative cognitive dysfunction. Participants will be randomly assigned to receive either the supplement plus standard care, or standard care alone, and their thinking abilities will be tracked using memory and attention tests.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Palmitoylethanolamide and Luteolin (PEALut) oral suspension

What this could lead to

If it works, this could offer a simple, safe supplement to help older adults maintain their memory and thinking after heart surgery.

What could go wrong

This is a small, early-stage trial. The supplement may not prevent cognitive decline, and results may not apply to all types of surgery or patients.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for POSTOPERATIVE COGNITIVE DYSFUNCTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Cognitive Dysfunction Neuroinflammatory Diseases Postoperative Cognitive Complications

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

More trials for these conditions

Other studies related to the condition(s) this trial covers.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Fondazione IRCCS San Gerardo dei Tintori

    Monza, Italy

    Contact Email: •••••@•••••